Omni Health Inc (OMHE)

[mattsinvestmentclub]

its called reformulations:

lets start with

CELEB CREAM
originally created by world renowned dermatologist

Dr. Lawrence E. Samuels, the chief of dermatology at St. Luke's Hospital in St. Louis and a widely respected leader in his medical field, has been developing anti-aging, skin care, and hair care products since 1966. Dr. Samuels is a member of the teaching faculty at Washington University Medical School and he has provided expert dermatological care for more than three decades. He's a board-certified dermatologist and a member of the American Academy of Dermatology and the American Society for Dermatologic Surgery.

"This Celeb Cream addition will allow us to fast track Omni Health's entry into the anti-aging and specialty skincare industries, a highly profitable marketplace that we have targeted as one of the key growth areas," said Omni Health CEO Andrey Soloviev.

now lets look at where omni see's celeb cream as part of its folio:

THE COMPANIES PITCH DECK MADE ITS INTENTIONS CLEAR:

CELEB CREAM MARKETING CAMPAIGN RE-ADVERTISED NAMED AS RELIEVEMD.
TRADEMARK:


https://www.tomoson.com/p/relievemd



NOW LETS LOOK AT WHOM IS COMPLETING THE REFORMULATIONS FOR OMNI:

The Scientific Advisory Board will serve as a vital strategic network of scientific, medical and clinical experts to Omni Health as the company prepares to bring, acquire and develop innovative products into its pipeline.

Dr. Arkady Uryash, MD, PhD.
Dr. Uryash is the Director of Biomedical Research for the internship program of Mount Sinai Medical Center and Associate Professor of Cardiology and Vascular Biology for Mount Sinai Center in Miami. As an experienced Director of Research and Development, Dr. Uryash is knowledgeable in U.S. Food and Drug Administration (FDA) regulation, research and development, and clinical trials. Dr. Uryash has previously served as CEO of a biotech company and is experienced in the management of biotech company operations, interdisciplinary team recruitment, and intellectual property. He has published numerous articles in peer-review journals and is a recipient of several academic awards and honors.

"The formation of our Scientific Advisory Board serves as a clear endorsement, bringing merit to the scientific, medical and commercial potential of our vision to take Omni Health to the next level, which we believe could be transformative for medicine and for the company," concluded Andrey Soloviev.